Showing results (201-210 of 344) with videos related to
Sort By:
Pageof 35
Lung Cancer (Amsterdam, Netherlands)|June 21, 2011
Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapySeung Tae Kim, Ji Eun Uhm, Jeeyun Lee, et al.Cancer|April 7, 2021
High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy ProgramSehhoon Park, Steve Olsen, Bo Mi Ku, et al.The Korean Journal of Internal Medicine|April 4, 2020
Induction chemotherapy followed by concurrent chemoradiotherapy versus CCRT for locally advanced hypopharynx and base of tongue cancerSung Hee Lim, Jong-Mu Sun, Joohyun Hong, et al.European Journal of Cancer (Oxford, England : 1990)|November 9, 2021
Extrapulmonary tuberculosis in patients with RET fusion-positive non-small cell lung cancer treated with pralsetinib: A Korean single-centre compassionate use experienceYong-Pyo Lee, Byeong-Ho Jeong, Yeonghee Eun, et al.The Annals of Thoracic Surgery|February 21, 2026
Prognosis of Isolated Cervical Node Recurrence Following Esophagectomy With Two-Field Lymphadenectomy for Esophageal Squamous Cell CarcinomaYeong Jeong Jeon, Jeong A Son, Junghee Lee, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 15, 2022
Bevacizumab Plus Atezolizumab After Progression on Atezolizumab Monotherapy in Pretreated Patients With NSCLC: An Open-Label, Two-Stage, Phase 2 TrialJiyun Lee, Jiae Koh, Hee Kyung Kim, et al.Esophagus : Official Journal of the Japan Esophageal Society|December 11, 2023
Prognostic role of pathologic status other than complete response after neoadjuvant therapy followed by surgery in esophageal squamous cell carcinomaSeong Yong Park, Junghee Lee, Dongryul Oh, et al.Cancer Research and Treatment|October 17, 2023
Neoadjuvant Nivolumab Therapy for Esophageal Squamous Cell Carcinoma: A Single-Arm, Phase II StudySehhoon Park, Yurimi Lee, Jiyun Lee, et al.The Lancet. Oncology|December 25, 2025
Tiragolumab plus atezolizumab and chemotherapy as first-line treatment for patients with unresectable oesophageal squamous cell carcinoma (SKYSCRAPER-08): a randomised, double-blind, placebo-controlled, phase 3 trialChih-Hung Hsu, Zhihao Lu, Shegan Gao, et al.Expert Opinion on Investigational Drugs|August 1, 2020
Phase I clinical trial of KML001 monotherapy in patients with advanced solid tumorsSeokuee Kim, Sujong Kim, Young Suk Park, et al.Pageof 35